A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 476.68
C 34.23
GOOG 609.85
BAC 8.13
RIMM 16.49

Recently Added

SHMX 0.00
NBTH 12.79
COHO 0.00
PZZI 6.19
AIMH 0.01

Gaining Speed

COHO 0.00
SHMX 0.00
NBTH 12.79
AVEW 0.00
IDVC 0.35
6.79 +0.00 (0.00%) FOLD

Click Here to Receive Instant E-mail and RSS Alerts


Trade FOLD now with

Stock Details

Last Trade:6.79 Change:+0.00 (0.00%) Prev Close:6.79 Open: 6.85 Days Range:6.69 – 6.94 52 Week Range: 2.10 - 8.12 Volume:135292 P/E: N/A
EPS:-1.52

Member Comments

No member comments available for FOLD


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/09/12

Recent Alert on 01/30/12 at 9:54am
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); WORLD Phase 3 Data Suggest 50-70% Prevalence

Canaccord Genuity reiterates a 'Buy' on Amicus Therapeutics (NASDAQ: FOLD) price target of $10.00 Analyst, Ritu Baral, said, "Reiterate rating and price target on migalastat potentially positive pivotal Fabry monotx data Q3/12, mono and combotx... Read More

Recent Alert on 01/23/12 at 7:32am
Amicus Therapeutics (FOLD) Promotes Bradley Campbell to Business Chief
Recent Alert on 01/09/12 at 8:55am
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Positive Phase 2 Amigal Combo Data: Boosted ERT Potency
Recent Alert on 01/09/12 at 7:36am
Amicus Therapeutics (FOLD) Reports FY12 Strategic Outlook and Guidance
Recent Alert on 01/06/12 at 7:41am
Amicus (FOLD) Reports Preliminary Data from Study 013 Phase 2

View AllRecent Press Releases

Press Release on 02/08/12 at 9:30am
Amicus Therapeutics to Announce Fourth Quarter and Full-Year 2011 Financial Results on February 13, 2012
Press Release on 02/07/12 at 7:30am
Amicus Therapeutics Awarded Grant From Muscular Dystrophy Association for Pompe Disease Program

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 01/30/12 at 3:49pm
Best Performing Stocks Year To Date
Blog Posts on 09/14/11 at 5:06am
12 Oversold Biotech Stocks Being Bought Up By Smart Money
Blog Posts on 09/12/11 at 9:49am
ETF Deathwatch For September 2011: Ben Graham Has Left The Building
Blog Posts on 02/28/11 at 10:46am
22 Companies With Market Cap Over $50 Million and 100%-Plus Sales Growth Forecast for 2011-12
Blog Posts on 11/08/10 at 8:35pm
Amicus Therapeutics CEO Discusses Q3 2010 Results - Earnings Call Transcript